Overview An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation Status: Completed Trial end date: 2005-04-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the long-term safety of dapoxetine in men with rapid ejaculation. Phase: Phase 3 Details Lead Sponsor: Alza Corporation, DE, USA